After the original FY2025/26 deep dive (5.4/10), JAT's CEO met us and explained the "why" behind the numbers. This update independently verifies each CEO response against external evidence — the Bangladesh election outcome, the live Strait of Hormuz conflict, crude-oil and solvent-chemistry reality, and the New Zealand recession. The DCF is then re-run with fact-checked assumptions.
Most "CEO responded" follow-ups are PR. This one does the opposite: it takes every explanation the CEO gave and tests it against verifiable, independent evidence. Some claims check out completely. One is technically true but understated — the situation is worse than management implied. One can't be verified yet. And one still doesn't add up arithmetically. Here's the honest scorecard.
The election is confirmed and decisive: held 12 February 2026, the BNP under Tarique Rahman won a two-thirds majority (~211–212 of 299 seats), ending the 15-year Hasina era and the post-2024 interim-government limbo. So the CEO is right that there's now a clear, elected government — a genuine improvement on the chaos of 2024–25 that hammered JAT's Bangladesh operations.
But "stable" is the CEO's optimism, not the consensus. Independent analysts are explicit that stability is not yet restored — CSIS titled its analysis "Stability Will Be Earned Through Delivery, Not Declarations." GDP growth slid to the mid-4% range (from 6–7% under the prior regime), inflation is still ~9%, foreign reserves ~$30bn, and there's been post-election violence plus an opposition boycott over reform sequencing. Bangladesh also faces LDC graduation in November 2026, which removes trade preferences.
Sources: CSIS (Apr 2026), Carnegie Endowment (May 2026), Asia Pacific Foundation, ICWA — election result and macro data independently confirmed across multiple outlets.The honest read: a 20–30% rebound is plausible precisely because the base collapsed. JAT's export share fell from 35% to 26% as Bangladesh cratered — so a chunk of "growth" is just recovering lost ground, not new expansion. With an elected government and a stabilising (if fragile) economy, demand for furniture coatings should recover. But mid-4% GDP growth and 9% inflation are not a boom backdrop, and LDC graduation is a 2026 headwind.
Why it matters for the earnings story: Bangladesh hosts JAT's alkyd-resin plant — part of the backward-integration that lifted gross margin from 34% to 38%. When Bangladesh volumes fell, that plant became an under-utilised fixed-cost drag. If volumes recover 20–30%, the operating leverage works in reverse — the same fixed cost spread over more units lifts margin. This is the single most important margin swing factor for FY2027, more than Mirotone or emulsion. A real Bangladesh recovery is where the gross-margin gain finally reaches the operating line.
The chemistry checks out completely. Solvent-based nitrocellulose wood lacquers — JAT's core Sayerlack product (57% market share) — are 60–80% solvent by content, and those solvents (ethyl acetate, butyl acetate, MEK, toluene, glycol ethers) are petrochemical derivatives priced directly off crude oil. The NC binder itself uses cotton linters, but the dominant cost and volume input is the crude-linked solvent base. So when crude spikes, JAT's largest, highest-margin product line takes a direct input-cost hit. The CEO's raw-material explanation is not spin — it's accurate industrial chemistry.
Sources: Patent & technical literature on NC lacquer formulation (USPTO; coatings chemistry references) confirm 60–80% solvent content and petrochemical solvent base.This is the most important correction in the entire fact-check. The CEO framed the Middle East as a short-term wrinkle that gets "sorted in a few months." The reality as of June 2026 is far more serious:
Opportunistic bulk-buying on dips is reasonable procurement. But in a war-driven, $90–111 whipsawing crude market, it becomes commodity speculation bolted onto a paint company. Buy early before a further dip and you've tied up cash in inventory at the wrong price (this is part of why inventory sits at 154 days). It also makes the balance sheet harder to read quarter-to-quarter. It's not wrong — but it's a risk that belongs in disclosure, and it's another reason the cash cycle will stay lumpy while the war continues.
The strategic logic is sound and JAT has a real track record of R&D-led results. The single best proof is the backward-integration win the original analysis already credited: JAT built an acrylic-binder plant in Sri Lanka and an alkyd-resin plant in Bangladesh, which held cost-of-sales growth to +3% against +9% revenue and lifted gross margin from 34% to 38%. That is exactly what an R&D-and-formulation capability delivers — making your own inputs instead of importing them. The FY2026 report also shows 15 new product launches (vs 4 the prior year) with 10 more in the pipeline.
The caveat: R&D is a cost today and a payoff later — and only if it produces defensible products or margin. A 12.5× team expansion is a bet, not a guarantee. The evidence that JAT converts R&D into margin (the binder/resin plants) is genuine, so this is a credible investment — but it's the reason operating profit was flat this year, and it only "works" if FY2027 shows the new products and formulations translating into either revenue or further margin. Watch the new-product pipeline and gross margin together.
New Zealand's economic weakness through 2024–2025 is well established — the economy fell into recession with one of the sharper contractions in the OECD, the central bank cut rates aggressively, and asset/business valuations compressed. So "we bought a 90-year brand cheap because NZ was in a downturn" is entirely consistent with the macro reality. A 90-year wood-coatings brand changing hands for ~USD 1.6M only makes sense in a distressed-seller context — which supports the CEO's account and makes an IFRS 3 bargain-purchase gain the expected accounting outcome, not a hidden trick.
The strategy is logical: own a credible ANZ brand (Mirotone), manufacture in low-cost Sri Lanka, sell into Australia at developed-market prices, and capture the manufacturing margin plus dollarised revenue. That's a genuine, coherent thesis — far better than the "transformative" framing in the annual report suggested.
But Australia is genuinely brutal. It's dominated by Dulux (DuluxGroup), Resene, Wattyl/Hempel and PPG. Mirotone is a niche industrial wood-coatings brand, not a decorative giant — so the realistic target is the specialty furniture/joinery coatings niche, not mass-market paint. That's a smaller, winnable beachhead, but it's small. And there's a near-term complication the CEO didn't flag: the Hormuz oil shock has disrupted shipping into ANZ specifically (reports of fuel shortages and flight cancellations into New Zealand during the crisis), which raises freight costs on exactly the Sri Lanka–Australia export route the thesis depends on.
What's confirmed and credible: The "emulsion as shelf-space defence" logic is sound — hardware shops tie wood-coating shelf access to emulsion volumes, so JAT must carry emulsion to protect its 57% wood-coatings franchise. And the CEO's own admission that LKR 1bn of extra revenue moved total market share only 0.5–1% is refreshingly honest — it confirms the original analysis's point that the wall-paint category push hasn't materially moved the needle. The online D2C model (cutting the ~40% distributor margin) is a smart channel choice.
What still doesn't add up — see the math box. Three numbers the CEO gave (9% of emulsion · "only sells brilliant white" · 20–25% of brilliant white) cannot all be true on the same base. This needs a written reconciliation before any of those figures is broadcast as fact.
The reported figures were S&D +31% and admin +44%. The CEO's ex-Mirotone split (+17% / +30%) is internally plausible and consistent with the R&D explanation, and it materially improves the operating-leverage picture: ex-acquisition, S&D growth (+17%) is only modestly above revenue (+9%), and the one-off acquisition cost inside admin should not recur. This breakdown does not yet appear as a separate disclosed line in the published accounts. Until it is reflected in a filed document, it is presented here as management's stated position rather than a figure independently verifiable from the financial statements.
Net debt rose 15% to LKR 2,189M. Mirotone was ~LKR 489M total (with ~293M into PP&E) — so a meaningful chunk of the debt increase does line up with the acquisition plus capex, supporting the CEO's claim that the rise is acquisition-driven rather than operational distress. However, the original analysis flagged that the 267-day cash-conversion cycle also consumed cash — and the Hormuz-driven upfront supplier payments (verified above) pulled even more cash out. So "the debt rise is purely Mirotone" is too clean: Mirotone explains part, but the working-capital blowout (now confirmed as partly war-driven and likely to persist) is a second, independent cash drain. The audited cash-flow statement — operating cash flow vs the acquisition line — is the document that would show how much of the borrowing funded the deal versus plugged a working-capital gap. That distinction is material to the full assessment of capital discipline.
The original deep dive's base-case DCF landed at ~LKR 21 against a market price of ~LKR 39. The CEO's verified context justifies modestly more optimistic operating assumptions — mainly a Bangladesh-driven margin recovery and the R&D/backward-integration payoff — but the live Hormuz war caps how far you can push them, because input costs and the cash cycle stay under pressure through much of FY2027. Here's the honest before/after.
What changed and why: revenue CAGR nudged up (7%→8.5%) for the Bangladesh recovery + Mirotone optionality; EBIT margin up (14.5%→15.5%) because the verified backward-integration / R&D story plus a Bangladesh volume recovery should let the 38% gross margin reach the operating line as one-off costs roll off. WACC held at 15% — the Hormuz war is a reason not to lower the discount rate despite the better operating story; near-term cash-flow risk is higher, not lower. The result: fair value rises modestly from ~21 to ~24, but the stock at ~39 still embeds the bull case.
The fact-check moved the score less than the CEO's raw answers alone would have. Reason: while R&D, Mirotone and Bangladesh context are genuine positives, the verified Hormuz war makes the cash-flow and input-cost risk worse than the original analysis assumed — partly offsetting the gains.
The CEO's explanations are, on independent checking, largely honest and mostly verifiable — that's a credibility win for management. R&D, Mirotone and the emulsion logic all hold up. But two hard facts cap the upgrade to +0.3: (1) the Strait of Hormuz war is real, severe, and — per the official US energy outlook — likely to pressure JAT's input costs and cash cycle into early 2027, so the biggest red flag is reinforced, not resolved; and (2) the stock at ~LKR 39 still trades roughly 38% above even the improved DCF base case. Excellent franchise, better-explained year, genuinely tough external environment — and a price that still needs the bull case to come true.
Four of the CEO's six explanations hold up fully against independent evidence. One is technically accurate but understates the severity of an active geopolitical conflict. One remains arithmetically unresolved pending further disclosure. Taken together, the context moves the overall assessment modestly — but not enough to close the gap between the current price and what the verified fundamentals support.
| Claim | Verdict | Impact on analysis |
|---|---|---|
| NZ recession / Mirotone distressed buy | ✓ Verified | Mirotone reframed as opportunistic; IFRS 3 gain is expected, not a trick |
| NC / solvent crude-oil dependency | ✓ Verified | Working-capital deterioration has a legitimate external cause |
| R&D investment driving admin costs | ✓ Verified by track record | 34%→38% gross-margin improvement is direct evidence R&D converts to margin |
| Bangladesh election / stabilisation | ✓ Election confirmed | BNP majority real; recovery fragile, GDP mid-4%, inflation ~9% |
| Middle East "sorted in a few months" | ▼ Understated | Hormuz effectively closed since 4 Mar; EIA expects normalisation early 2027 — CCC pressure persists longer than implied |
| Brilliant white 20–25% share | ? Unresolved | Likely refers to online channel, not total market — materially different claim; disclosure needed |
| Ex-Mirotone S&D +17%, admin +30% | ◆ Management guidance | Plausible; not yet in published accounts — treat as management's stated position |